Search Results for: iPS cells

Weekend reads: ES cell research polls well, Gordie Howe, MS, IPS cells, and more

Gallup-Poll-stem-cells

Here are some headlines & articles worth a look and some thought on stem cell and biomedical science more generally. Gallup finds in a new poll that 60% of Americans surveyed find human embryonic stem celsl research “largely acceptable”. On the other hand human reproductive cloning is highly frowned upon, sandwiched in the “highly unacceptable […]

Weekend reads: ES cell research polls well, Gordie Howe, MS, IPS cells, and more Read More »

Pain in a dish? Drug testing bench to bedside with IPS cells

inherited-erythromelalgia

A new study on treating pain with a unique stem cell connection caught my attention. The paper was from a team at Pfizer led by Edward B. Stevens. Talk about bench to bedside, these researchers went all the way from patients to patient somatic cells to reprogrammed IPSC to neurons to model pain in a dish

Pain in a dish? Drug testing bench to bedside with IPS cells Read More »

Review of Mitalipov Nature paper: cloned ES cells vs iPS cells

NT-ESC

Just how good are human embryonic stem (ES) cells made by therapeutic cloning via nuclear transfer, with the successful technique first reported by the lab of Shoukhrat Mitalipov at OHSU last year? How do they compare to induced pluripotent stem (iPS) cells or traditional ES cells made from IVF embryos? A new paper in Nature directly tackles these

Review of Mitalipov Nature paper: cloned ES cells vs iPS cells Read More »

Masayo Takahashi Interview on iPS cells, clinical studies, & more

Masayo-Takahashi

In the interview below I talk with Dr. Masayo Takahashi, who is leading a team conducting the first ever in-human clinical study based on iPS cells. The work began with patient enrollment on Aug. 1, 2013 in Japan. Masaya Takahashi background 1. Can you tell us a bit about your background? As an M.D./Ph.D. and

Masayo Takahashi Interview on iPS cells, clinical studies, & more Read More »

Stem cell journal club: dishing on Nature paper on making iPS cells inside mice

What if you could reprogram cells inside of an organism to a different fate and, for instance, make IPS cells? We can, right? But when most of us think about making induced pluripotent stem (iPS) cells, we imagine it all happening in a little plastic dish in our labs or in our colleague’s labs, not

Stem cell journal club: dishing on Nature paper on making iPS cells inside mice Read More »

Stem cell field mostly taking a wait-and-see attitude toward all chemical iPS cells

I recently did a poll on people’s reactions to the new paper reporting use an all-chemical approach to making iPS cells through cellular reprogramming. I got a good number of responses relatively quickly. The results so far suggest that by far most people think it is too soon to know the importance of this new

Stem cell field mostly taking a wait-and-see attitude toward all chemical iPS cells Read More »

Janet Rossant, ISSCR President, on her goals, cloning, non-compliant clinics, iPS cells, and future of field

New ISSCR President, Dr. Janet Rossant, kindly agreed to do an interview with me focused on the future of ISSCR, her plans for her tenure, and some key issues in the field. Dr. Rossant is Chief of Research at The Hospital for Sick Children in Toronto. 1. The stem cell arena is a very rapidly changing one

Janet Rossant, ISSCR President, on her goals, cloning, non-compliant clinics, iPS cells, and future of field Read More »

Perspectives on human micro liver structures made from iPS cells

The big stem cell buzz the last day or two has been the news exploding across mainstream media outlets about laboratory-produced human liver grown from stem cells. It’s good news to be sure as it would seem we might be one important step closer to a new reality for millions of people suffering from liver disease.

Perspectives on human micro liver structures made from iPS cells Read More »